Sirinda Thewaanukhor

Sirinda Thewaanukhor

Auto-generated profile, based on publicly available information

Sirinda Thewaanukhor


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
ARArtitaya Rongjumnong
Artitaya Rongjumnong
AMAnupong Makeudom
Anupong Makeudom
PKPapawarin Karamart
Papawarin Karamart
STSirinda Thewaanukhor
Sirinda Thewaanukhor
OVOrrapan Vito
Orrapan Vito
AMAtthapan Morchang
Atthapan Morchang
Colorectal cancer (CRC) remains one of the leading causes of cancer-related mortality worldwide. The development of novel therapeutic agents with improved efficacy and selectivity is therefore needed. This study investigated the anticancer activity of Clausena lansium ethyl acetate fruit extract (CLEA) and its major compound, methyl carbazole-3-carboxylate (MC3C), against CRC cells. The cytotoxic activity of CLEA was evaluated in several cancer cell lines. SW-480 colorectal cancer cells were the most sensitive to CLEA treatment, with an IC₅₀ value of 10.27 ± 6.90 μg/mL after 48 h. CLEA significantly suppressed colony formation, cell migration, and induced apoptosis in CRC cells in a dose-dependent manner. Phytochemical investigation identified methyl carbazole-3-carboxylate (MC3C) as a major compound present in CLEA. Comparable to its crude extract, MC3C exhibited anticancer activity against SW-480 cells, with an IC₅₀ value of 31.44 ± 2.53 μM. Treatment with MC3C at 40 μM suppressed colony formation, cell migration and induced apoptosis in SW-480 cells. Label-free proteomic analysis identified 56 significantly altered proteins in MC3C-treated SW-480 cells. Most of these proteins were associated with endoplasmic reticulum (ER) protein folding, apoptosis, and cell death pathways. Western blot analysis further demonstrated upregulated expression of the ER stress-related proteins GRP78 and PDIA3 upon treatment with MC3C. Collectively, these findings suggest that CLEA and MC3C exert the potent anticancer activity against CRC cells through activation of ER stress-related pathways, highlighting their potential as novel therapeutic agents.